These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 9278207
1. Pharmacokinetics of the S(+) and R(-) enantiomers of vigabatrin during chronic dosing in a patient with renal failure. Jacqz-Aigrain E, Guillonneau M, Rey E, Macher MA, Montes C, Chiron C, Loirat C. Br J Clin Pharmacol; 1997 Aug; 44(2):183-5. PubMed ID: 9278207 [Abstract] [Full Text] [Related]
2. Pharmacokinetics of the individual enantiomers of vigabatrin in neonates with uncontrolled seizures. Vauzelle-Kervroëdan F, Rey E, Pons G, d'Athis P, Chiron C, Dulac O, Dumas C, Olive G. Br J Clin Pharmacol; 1996 Dec; 42(6):779-81. PubMed ID: 8971436 [Abstract] [Full Text] [Related]
3. Vigabatrin. Clinical pharmacokinetics. Rey E, Pons G, Olive G. Clin Pharmacokinet; 1992 Oct; 23(4):267-78. PubMed ID: 1395360 [Abstract] [Full Text] [Related]
5. Vigabatrin: placental transfer in vivo and excretion into breast milk of the enantiomers. Tran A, O'Mahoney T, Rey E, Mai J, Mumford JP, Olive G. Br J Clin Pharmacol; 1998 Apr; 45(4):409-11. PubMed ID: 9578192 [Abstract] [Full Text] [Related]
6. Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl GABA) in epileptic children. Rey E, Pons G, Richard MO, Vauzelle F, D'Athis P, Chiron C, Dulac O, Beaumont D, Olive G. Br J Clin Pharmacol; 1990 Aug; 30(2):253-7. PubMed ID: 2206786 [Abstract] [Full Text] [Related]
7. Pharmacokinetic interaction studies between felbamate and vigabatrin. Reidenberg P, Glue P, Banfield C, Colucci R, Meehan J, Rey E, Radwanski E, Nomeir A, Lim J, Lin C. Br J Clin Pharmacol; 1995 Aug; 40(2):157-60. PubMed ID: 8562299 [Abstract] [Full Text] [Related]
8. Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer. Haegele KD, Schechter PJ. Clin Pharmacol Ther; 1986 Nov; 40(5):581-6. PubMed ID: 3769388 [Abstract] [Full Text] [Related]
9. A comparison of population and standard two-stage pharmacokinetic analyses of vigabatrin data. Yu DK, Hutcheson SJ, Wei G, Bhargava VO, Weir SJ. Biopharm Drug Dispos; 1994 Aug; 15(6):473-84. PubMed ID: 7993985 [Abstract] [Full Text] [Related]
11. Clinical pharmacokinetics of gabapentin after administration of gabapentin enacarbil extended-release tablets in patients with varying degrees of renal function using data from an open-label, single-dose pharmacokinetic study. Lal R, Sukbuntherng J, Luo W, Chen D, Blumenthal R, Ho J, Cundy KC. Clin Ther; 2012 Jan; 34(1):201-13. PubMed ID: 22206794 [Abstract] [Full Text] [Related]
12. High-performance liquid chromatographic analysis of vigabatrin enantiomers in human serum by precolumn derivatization with o-phthaldialdehyde-N-acetyl-L-cysteine and fluorescence detection. Vermeij TA, Edelbroek PM. J Chromatogr B Biomed Sci Appl; 1998 Sep 25; 716(1-2):233-8. PubMed ID: 9824236 [Abstract] [Full Text] [Related]
13. Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy. Mattson RH, Petroff OA, Rothman D, Behar K. Acta Neurol Scand Suppl; 1995 Sep 25; 162():27-30. PubMed ID: 7495186 [Abstract] [Full Text] [Related]
20. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review. Hancock E, Osborne JP. J Child Neurol; 1999 Feb 25; 14(2):71-4. PubMed ID: 10073425 [Abstract] [Full Text] [Related] Page: [Next] [New Search]